In situ humoral selection in human lupus tubulointerstitial inflammation
A. J. Kinloch, Y. Asano, A. Mohsin, C. J. Henry, R. Abraham, A. Chang, C. Labno, P. C. Wilson, M. R. Clark
Abstract
ABSTRACTIn human lupus nephritis, tubulointerstitial inflammation (TII) is associated with in situ expansion of B cells expressing anti-vimentin antibodies (AVAs). The mechanism by which AVAs are selected is unclear. Herein, we demonstrate that AVA somatic hypermutation and selection increase affinity for vimentin. However, enzyme-linked immunosorbent assays (ELISAs) suggested that affinity maturation might be a non-specific consequence of increasing polyreactivity. Subsequent multi-color confocal microscopy studies indicated that while TII AVAs often appeared polyreactive by ELISA, they bound selectively to vimentin fibrils in whole cells or inflamed renal tissue. Using a novel machine learning pipeline (CytoSkaler) to quantify the cellular distribution of antibody staining, we demonstrated that TII AVAs were selected for both enhanced binding and specificity in situ. These data suggest a new approach to assess and define antibody polyreactivity based on quantifying the distribution of binding to native and contextually relevant antigens.Competing Interest StatementThe authors have declared no competing interest.View Full Text
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Resolution of in situ inflammation in human lupus nephritis into principal immune cell trajectories
Gabriel Casella, Madeleine S. Torcasso, … Marcus R. Clark·bioRxiv·Feb 17, 2025
- CD8 T lymphocytes infiltrate the kidneys and correlate with disease progression in B6.NZMSle1/Sle2/Sle3 lupus mice
Pauline Montigny, Selda Aydın, … Pierre G. Coulie·bioRxiv·Nov 3, 2025
- Targeting B and T lymphocyte attenuator regulates lupus disease development in NZB/W mice
Léa Gherardi, Lucie Aubergeon, … Fanny Monneaux·ImmunoTargets and TherapyPeer-reviewed·Jan 1, 2025
- CD11b suppresses TLR7-driven inflammatory signaling to protect against lupus nephritis
Xiaobo Li, Veronica Villanueva, … Vineet Gupta·bioRxiv·Jul 26, 2024
- Facile generation of biepitopic antibodies with intrinsic agonism for activating receptors in the tumor necrosis factor superfamily
H. S. Jhajj, J. S. Schardt, … P. M. Tessier·bioRxiv·Dec 11, 2023
- Bivalency of natalizumab promotes inhibition of dynamic VLA-4 adhesion beyond affinity gain
Marie‐Pierre Valignat, Martine Biarnes‐Pelicot, … Philippe Robert·Integrative BiologyPeer-reviewed·Jan 1, 2026